Sukhvinder Sidhu

Global Head of Pharmacology - Oncology

Sanofi-Aventis Recherche et Developpement Vitry-sur-Seine Alfortville

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sukhvinder Sidhu serves as the Global Head of Pharmacology - Oncology at Sanofi-Aventis Recherche et Developpement Vitry-sur-Seine, France. His research primarily focuses on cancer biology, with recent articles exploring synthetic lethality in colorectal and pancreatic cancers, the role of TEAD inhibitors in sensitizing KRAS G12C inhibitors, and the importance of YAP1 in malignant mesothelioma. Dr. Sidhu's work contributes significantly to the understanding of therapeutic strategies against various malignancies.

Articles (5)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (2)

ludovic Martinet

head of Team 13

FRANCE

View details

Jean-Luc Teillaud

INSERM

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sukhvinder Sidhu

Research Interests

Explore related searches

Contact this professor

About

Articles (5)

Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss

Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss

TEAD Inhibitors Sensitize KRAS G12C Inhibitors via Dual Cell Cycle Arrest in KRAS G12C-Mutant NSCLC.

SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma.

YAP1 is essential for malignant mesothelioma tumor maintenance.

Collaborators (2)

ludovic Martinet

Jean-Luc Teillaud

Make your next move.